NCT07193147View on ClinicalTrials.gov

Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 13, 2025

Primary Completion Date

July 14, 2026

Study Completion Date

November 4, 2026

Conditions
Diabetes
Interventions
DRUG

GZR4

GZR4 s.c., single-dose

Trial Locations (1)

276000

Gan & Lee Pharmaceuticals Shandong Co., Ltd., Linyi

Sponsors
All Listed Sponsors
lead

Gan & Lee Pharmaceuticals.

INDUSTRY